LW
Li Watsek Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
8.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| – | – | 1 | +5.9% |
0
%
| 3 Dec ‘25 2 days ago |
|
|
|
Overweight
Maintained
| $254 |
24%
upside
| 5 | +12% |
0
%
| 13 Oct ‘25 1 month ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +8.3% |
0
%
| 2 Oct ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| – | – | 3 | +14% |
0
%
| 9 Sep ‘25 2 months ago |
|
|
|
Overweight
Upgraded
| – | – | 2 | +61% |
0
%
| 30 Jul ‘25 4 months ago |
|
|
|
Overweight
Reiterated
| – | – | 2 | +30% |
0
%
| 26 Jun ‘25 5 months ago |
|
|
|
Overweight
Reiterated
| – | – | 1 | -42% |
0
%
| 27 Mar ‘25 8 months ago |
|
|
|
Overweight
Reiterated
| – | – | 2 | -31% |
0
%
| 26 Mar ‘25 8 months ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +39% |
0
%
| 14 Mar ‘25 8 months ago |
|
|
|
Overweight
Reiterated
| – | – | 1 | -33% |
0
%
| 7 Feb ‘25 10 months ago |
|
|
|
Overweight
Reiterated
| – | – | 2 | -11% |
0
%
| 24 Jan ‘25 10 months ago |
|